Radiomics-Based Phenotyping for Treatment Optimization of HER2+ Breast Cancer A second Ignition Award is going to ... Launching a Multiplex BRCA1/RAD51C ddPCR Methylation Assay as a Clinical HRD Test ...

Previous work from other laboratories showed that PARP inhibitors are particularly toxic to cells with defects in the homologous recombination (HR) repair pathway, including breast and ... resistance ...

A Michigan State University researcher's new model for studying breast cancer could help scientists better understand why and ...

University of Kentucky Markey Cancer Center researchers identified a protein that could be key to developing new treatments ...

Mabel Mardones, MD, Rocky Mountain Cancer Centers, discusses the future of HR+/HER2– breast cancer treatment, focusing on the importance of biomarkers and the potential of SIRDs to improve patient ...

A new genetic study from researchers at Michigan State University could help scientists gain a deeper understanding of where ...

Breast cancer treatments, while life-saving, can impact a woman's fertility. Chemotherapy and radiation therapy, in particular, can damage ovarian function, leading to difficulties conceiving.

October is Breast Cancer Awareness Month — a worldwide campaign to raise awareness of the devastating disease and promote early detection through screenings. About one in eight women will be ...

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.

An FDA panel on Thursday endorsed a cryoablation system as an alternative to surgery for some early breast cancer patients.

Breast canceris a significant global public health challenge, with 2.3 million new cases and 700,000 deaths every year. Approximately 80% of patients with primary breast cancer can be cured, if ...